Placeholder

Advocacy Relations: Finding Common Ground

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 433. Category: .

Product Description

Everyone is familiar with the famous looped ribbons associated with the various disease awareness campaigns, such as Breast Cancer Awareness Month and the yellow “Livestrong” wristbands of the Lance Armstrong Foundation to generate cancer awareness. But the public may not be aware that these programs originated through, or were made possible by, the support of pharmaceutical companies. Many of the industry’s other nonbranded advocacy efforts also are less well known, such as health literacy programs and outreach programs to caregivers.
Through partnerships with advocacy groups and the development of their own outreach programs, pharmaceutical companies are going beyond solely developing medicines. By finding common ground with the advocacy groups that represent specific patient populations, the pharmaceutical industry can move beyond being seen as just a manufacturer and marketer of medicines to being viewed as an ally and partner in a patient’s health and well-being….

Sidebars:
Building Strong Pharma-Advocacy Partnerships
Good Will for Good Returns
Collaborations at Work

Thought Leaders
Scott D. Berns, M.D., MPH, FAAP. VP of Chapter Programs, March of Dimes, White Plains, N.Y.; the mission of the March of Dimes is to improve the health of babies by preventing birth defects, premature birth, and infant mortality. For more information, visit marchofdimes.com.
Diane S. Blum, MSW. Executive Director CancerCare Inc., New York; CancerCare is a national nonprofit organization that provides free professional support services to anyone affected by cancer: people with cancer, caregivers, children, loved ones, and the bereaved. For more information, visit cancercare.org.
Teri P. Cox. Senior Managing Partner, Cox Communications Partners, Lawrenceville, N.J.; Cox Communications Partners combines clear vision, fresh thinking, and entrepreneurial energy with decades of leadership in corporate and healthcare communications and advocacy. For more information, e-mail coxcomptnr@aol.com.
Barbara DeBuono, M.D., MPH. Group Leader Public Health, Pfizer Health Literacy Initiative, Pfizer Inc., New York; Pfizer discovers, develops, manufactures, and markets leading prescription medicines for humans and animals and many of the world’s best-known consumer brands. For more information, visit pfizer.com.
Bob Franks. President, HealthCare Institute of New Jersey, Hillside, N.J.; The HealthCare Institute of New Jersey serves as a unified voice for the state’s research-based pharmaceutical and medical technology industry. For more information, visit hinj.org.
Jamie Lacey. Director, Media and Public Relations, MedImmune Inc., Gaithersburg, Md.; MedImmune, which is dedicated to advancing science to develop better medicines to help people have healthier, longer, and more satisfying lives, focuses on the areas of infectious diseases, cancer, and inflammatory diseases. For more information, visit medimmune.com.
Suzanne Mintz. President and Cofounder, The National Family Caregivers Association, Kensington, Md.; NFCA supports, empowers, educates, and speaks for the more than 50 million Americans who care for a chronically ill, aged, or disabled loved one. For more information, visit thefamilycaregiver.org.
Cathy Pollini. Senior Director, Corporate Planning and Communications, Eisai Inc., Teaneck, N.J.; Eisai is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co. Ltd., a research-based human healthcare company that discovers, develops, and markets products in more than 30 countries. For more information, visit eisai.com.
Roger Sullivan. Director, Resources and Alliances, C-Change, Washington, D.C.; C-Change is comprised of the nation’s key cancer leaders from government, business, and nonprofit sectors and aims to share the vision of a future where cancer is prevented, detected early, and cured or is managed successfully as a chronic illness. For more information, visit c-changetogether.com.
Mike Tringale, M.S.M. Director of Marketing and Communications, Asthma and Allergy Foundation of America (AAFA), Washington, D.C., AAFA is a nonprofit patient organization dedicated to improving the quality of life for people with asthma and allergies. For more information, visit aafa.org.
Rebecca Womble. Director of Business and R&D Communications, Bristol-Myers Squibb Co., New York; Bristol-Myers Squibb’s mission is to extend and enhance human life by providing the highest-quality pharmaceuticals and healthcare products. For more information, visit bms.com.

FEEDBACK